Terbinafine is More Effective than Itraconazole in Treating Toenail Onychomycosis: Results from a Meta-analysis of Randomized Controlled Trials

Journal of Cutaneous Medicine and Surgery

Volumn 7, Issue 4, 2003, Pages 306-311

  Krob, H Alexander ^a   Fleischer Jr , Alan B ^a   D'Agostino Jr , Ralph ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; ONYCHOMYCOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOE; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; FOOT DERMATOSES; HUMANS; ITRACONAZOLE; NAPHTHALENES; ONYCHOMYCOSIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0242415373     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-002-0139-9     Document Type: Article

References (26)

1. Hecker D. Current trends in onychomycosis therapy: a literature review. M Sinai J Med 1997; 64:399-405.
2. Hazen KC. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J Am Acad Dermatol 1998; 38:S37-41.
3. De Doncker P, Gupta AK. Itraconazole and terbinafine in perspective. From petri dish to patient. Postgrad Med 1999; July Spec No:6-11.
4. Gupta AK. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. Pharmacoeconomics 1998; 13:243-256.
5. Arikian SR, Einarson TR, Kobelt-Nguyen G, et al. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group. Br J Dermatol 1994; 130(Suppl 43):35-44.
6. Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol 1998; 134:1551-1554.
7. D'Agostino RB, Weintraub M. Meta-analysis: A method for synthesizing research. Clin Pharmacol ther 1995; 58:605-616.
8. D'Agostino Sr RB, Weintraub M, Russell HK, et al. The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta-analysis. Clin Pharmacol ther 1998; 64:579-596.
9. Yusef S, Peto R, Lewis J, et al. Beta blockage during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27:335-371.
10. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2:121-147.
11. Brautigam M, Nolting S, Schopf RE, et al. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group. BMJ 1995; 311:919-922.
12. Tosti A, Piraccini BM, Stinchi C, et al. Treatment of dermatophyte nail infection: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol 1996; 34:595-600.
13. De Backer M, De Keyser P, De Vroey C, et al. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day-a double-blind comparative trial. Br J Dermatol 1996; 134(Suppl 46):16-17.
14. Arenas R, Dominguez-Cherit J, Fernandez LM. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995; 34:138-143.
15. Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. BMJ 1999 Apr 17; 318:1031-1035.
16. Degreef H, del Palacio A, Mygind S, et al. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis. Acta Derm Venereol 1999 May; 79:221-223.
17. Goodfield MJ, Andrew L, Evans EG. Short term treatment of dermatophyte onychomycosis with terbinafine. BMJ 1992; 304:1151-1154.
18. Elewski BE, Scher RK, Aly R, et al. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis. Cutis 1997; 59:217-220.
19. Jones HE, Zaias N. Double blind-placebo controlled comparison of itraconazole capsules and placebo in onychomycosis of toenail. Int J Dermatol 1996; 35:589-590.
20. Drake LA, Shear NH, Arlette JP, et al. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. J Am Acad Dermatol 1997; 37:740-745.
21. Odom R, Daniel CR, Aly R. A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail. J Am Acad Dermatol 1996; 35:110-111.
22. Watson A, Marley J, Ellis D, et al. Terbinafine in onychomycosis of the toenail: a novel treatment protocol. J Am Acad Dermatol 1995; 33:775-779.
23. Svejgaard EL, Brandrup F, Kragballe K, et al. Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up. Acta Derm Venereol 1997; 7:66-69.
24. Shekelle PG, Morton SC. Principles of meta-analysis. J Rheumatol 2000; 27:251-252.
25. Khan KS, Wykes C, Gee H. Benzodiazepine use in pregnancy and major malformations or oval clefts. Quality of primary studies must influence inferences made from meta-analyses. BMJ 1999; 319(7214):919.
26. Holme I, Ekelund LG, Hjennann I, et al. Quality-adjusted metaanalysis of the hypertension/coronary dilemma. Am J Hypertens 1994; 7:703-712.